Management of gestational diabetes mellitus

Annunziata Lapolla, Maria Grazia Dalfrà, Domenico FedeleDepartment of Medical and Surgical Sciences, Padova University, ItalyAbstract: The incidence of gestational diabetes mellitus (GDM) is on the increase and, if not diagnosed, managed and treated adequately, can have unfavorable ma...

Full description

Bibliographic Details
Main Authors: Annunziata Lapolla, Maria Grazia Dalfrà, Domenico Fedele
Format: Article
Language:English
Published: Dove Medical Press 2009-06-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Online Access:http://www.dovepress.com/management-of-gestational-diabetes-mellitus-a3266
id doaj-755d59defcb24749b5835bf51869dabe
record_format Article
spelling doaj-755d59defcb24749b5835bf51869dabe2020-11-24T22:01:45ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy1178-70072009-06-012009default7382Management of gestational diabetes mellitusAnnunziata LapollaMaria Grazia DalfràDomenico FedeleAnnunziata Lapolla, Maria Grazia Dalfrà, Domenico FedeleDepartment of Medical and Surgical Sciences, Padova University, ItalyAbstract: The incidence of gestational diabetes mellitus (GDM) is on the increase and, if not diagnosed, managed and treated adequately, can have unfavorable maternal and fetal outcomes. Several studies have shown that glycemic values considered as adequate in the past when monitoring GDM failed to contain these adverse outcomes and randomized trials are needed to ascertain whether these targets should be lowered. Dietary restrictions remain the mainstay of GDM management and suitable physical exercise can help too. The use of rapid-acting insulin analogues (lispro and aspart) are novel treatments for improving metabolic control by reducing postprandial glycemia, while long-acting insulin analogues need to be evaluated by further studies for safety in clinical use before they can be prescribed. Numerous studies have found glyburide and metformin safe in women with GDM but more randomized controlled trials are needed, with a long-term follow-up of mother and child, to confirm these results.Keywords: gestational diabetes, glucose management, obstetric management, maternal complications, fetal complications http://www.dovepress.com/management-of-gestational-diabetes-mellitus-a3266
collection DOAJ
language English
format Article
sources DOAJ
author Annunziata Lapolla
Maria Grazia Dalfrà
Domenico Fedele
spellingShingle Annunziata Lapolla
Maria Grazia Dalfrà
Domenico Fedele
Management of gestational diabetes mellitus
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
author_facet Annunziata Lapolla
Maria Grazia Dalfrà
Domenico Fedele
author_sort Annunziata Lapolla
title Management of gestational diabetes mellitus
title_short Management of gestational diabetes mellitus
title_full Management of gestational diabetes mellitus
title_fullStr Management of gestational diabetes mellitus
title_full_unstemmed Management of gestational diabetes mellitus
title_sort management of gestational diabetes mellitus
publisher Dove Medical Press
series Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
issn 1178-7007
publishDate 2009-06-01
description Annunziata Lapolla, Maria Grazia Dalfrà, Domenico FedeleDepartment of Medical and Surgical Sciences, Padova University, ItalyAbstract: The incidence of gestational diabetes mellitus (GDM) is on the increase and, if not diagnosed, managed and treated adequately, can have unfavorable maternal and fetal outcomes. Several studies have shown that glycemic values considered as adequate in the past when monitoring GDM failed to contain these adverse outcomes and randomized trials are needed to ascertain whether these targets should be lowered. Dietary restrictions remain the mainstay of GDM management and suitable physical exercise can help too. The use of rapid-acting insulin analogues (lispro and aspart) are novel treatments for improving metabolic control by reducing postprandial glycemia, while long-acting insulin analogues need to be evaluated by further studies for safety in clinical use before they can be prescribed. Numerous studies have found glyburide and metformin safe in women with GDM but more randomized controlled trials are needed, with a long-term follow-up of mother and child, to confirm these results.Keywords: gestational diabetes, glucose management, obstetric management, maternal complications, fetal complications
url http://www.dovepress.com/management-of-gestational-diabetes-mellitus-a3266
work_keys_str_mv AT annunziatalapolla managementofgestationaldiabetesmellitus
AT mariagraziadalframpagrave managementofgestationaldiabetesmellitus
AT domenicofedele managementofgestationaldiabetesmellitus
_version_ 1725838720660144128